First Trust Advisors LP Repligen Corp Transaction History

First Trust Advisors LP

  • $95.8 Billion
  • Q1 2024

A detailed history of First Trust Advisors LP transactions in Repligen Corp stock. As of the latest transaction made, First Trust Advisors LP holds 254,397 shares of RGEN stock, worth $37.9 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
254,397
Previous 32,018 694.54%
Holding current value
$37.9 Million
Previous $5.76 Million 712.86%
% of portfolio
0.05%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$170.78 - $208.42 $38 Million - $46.3 Million
222,379 Added 694.54%
254,397 $46.8 Million
Q4 2023

Feb 13, 2024
SELL
$114.17 - $185.35 $1 Million - $1.63 Million
-8,782 Reduced 21.52%
32,018 $5.76 Million
Q3 2023

Nov 13, 2023
BUY
$138.78 - $176.51 $553,038 - $703,392
3,985 Added 10.82%
40,800 $6.49 Million
Q2 2023

Aug 14, 2023
SELL
$138.42 - $180.31 $468,274 - $609,988
-3,383 Reduced 8.42%
36,815 $5.21 Million
Q1 2023

May 15, 2023
SELL
$154.26 - $198.1 $14.7 Million - $18.8 Million
-94,993 Reduced 70.27%
40,198 $6.77 Million
Q4 2022

Feb 09, 2023
BUY
$162.42 - $220.56 $14.6 Million - $19.8 Million
89,724 Added 197.34%
135,191 $22.9 Million
Q3 2022

Nov 14, 2022
BUY
$160.42 - $256.21 $7.29 Million - $11.6 Million
45,467 New
45,467 $8.51 Million
Q2 2022

Aug 12, 2022
SELL
$140.68 - $188.02 $12.1 Million - $16.2 Million
-86,120 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$161.19 - $257.96 $7.9 Million - $12.6 Million
-49,004 Reduced 36.27%
86,120 $16.2 Million
Q4 2021

Feb 08, 2022
BUY
$247.59 - $304.47 $21.3 Million - $26.1 Million
85,857 Added 174.27%
135,124 $35.8 Million
Q3 2021

Nov 15, 2021
SELL
$194.77 - $324.21 $9.19 Million - $15.3 Million
-47,199 Reduced 48.93%
49,267 $14.2 Million
Q2 2021

Aug 16, 2021
SELL
$165.87 - $220.95 $7.35 Million - $9.79 Million
-44,324 Reduced 31.48%
96,466 $19.3 Million
Q1 2021

May 14, 2021
SELL
$180.37 - $226.26 $4.9 Million - $6.15 Million
-27,167 Reduced 16.17%
140,790 $27.4 Million
Q4 2020

Feb 02, 2021
SELL
$148.08 - $206.57 $2.79 Million - $3.9 Million
-18,872 Reduced 10.1%
167,957 $32.2 Million
Q3 2020

Nov 05, 2020
BUY
$122.51 - $158.27 $18.2 Million - $23.5 Million
148,657 Added 389.44%
186,829 $27.6 Million
Q2 2020

Jul 22, 2020
SELL
$94.33 - $140.48 $339,682 - $505,868
-3,601 Reduced 8.62%
38,172 $4.72 Million
Q1 2020

May 06, 2020
SELL
$84.96 - $109.14 $823,857 - $1.06 Million
-9,697 Reduced 18.84%
41,773 $4.03 Million
Q4 2019

Feb 03, 2020
BUY
$73.84 - $93.08 $574,992 - $724,813
7,787 Added 17.83%
51,470 $4.76 Million
Q3 2019

Nov 04, 2019
SELL
$76.65 - $95.51 $781,446 - $973,724
-10,195 Reduced 18.92%
43,683 $3.35 Million
Q2 2019

Jul 30, 2019
SELL
$54.2 - $85.95 $761,672 - $1.21 Million
-14,053 Reduced 20.69%
53,878 $4.63 Million
Q1 2019

May 09, 2019
SELL
$49.45 - $62.8 $82,680 - $105,001
-1,672 Reduced 2.4%
67,931 $4.01 Million
Q4 2018

Feb 07, 2019
BUY
$48.26 - $68.88 $20,365 - $29,067
422 Added 0.61%
69,603 $3.67 Million
Q3 2018

Oct 25, 2018
BUY
$46.8 - $58.97 $3.24 Million - $4.08 Million
69,181 New
69,181 $3.84 Million
Q1 2018

Apr 23, 2018
SELL
$30.92 - $37.27 $457,059 - $550,925
-14,782 Closed
0 $0
Q4 2017

Feb 08, 2018
SELL
$32.53 - $38.92 $1.05 Million - $1.25 Million
-32,128 Reduced 68.49%
14,782 $536,000
Q3 2017

Oct 24, 2017
BUY
$36.98 - $46.06 $1.73 Million - $2.16 Million
46,910
46,910 $1.8 Million

Others Institutions Holding RGEN

# of Institutions
522
Shares Held
53.2M
Call Options Held
1.05M
Put Options Held
228K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.27B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email